C5 and autoimmune polyendocrinopathy: They also observed that the C6-deficient mice phenotype or the administration of a C5 inhibitor prevented thrombosis, leading them to conclude that activation of the terminal complement pathway plays a crucial thrombogenic role in APS, although it requires an initiating stimulus.